PROCEEDS AGREEMENTProceeds Agreement • May 24th, 2023 • Baker Bros. Advisors Lp • Pharmaceutical preparations
Contract Type FiledMay 24th, 2023 Company IndustryWHEREAS, the Agent, in his capacity as a director of ACADIA Pharmaceuticals Inc. (the “Company”), received non-transferable options (the “Options”) to purchase 12,500 shares of the Company common stock (the “Stock”) according to the below Schedule A;
PROCEEDS AGREEMENTProceeds Agreement • January 10th, 2024 • Virginia
Contract Type FiledJanuary 10th, 2024 JurisdictionThis PROCEEDS AGREEMENT, dated [May 14], 2024 (this "Proceeds Agreement"), is among the VIRGINIA PUBLIC SCHOOL AUTHORITY, a public body corporate and instrumentality of the Commonwealth of Virginia ("VPSA"), and the counties and
PROCEEDS AGREEMENTProceeds Agreement • May 9th, 2024 • Baker Bros. Advisors Lp • Services-commercial physical & biological research
Contract Type FiledMay 9th, 2024 Company IndustryWHEREAS, the Agent, in his capacity as a director of Incyte Corporation (the “Company”), received non-transferable options (the “Options”) to purchase 15,000 shares of the Company common stock (the “Stock”) according to the below Schedule A;
PROCEEDS AGREEMENTProceeds Agreement • February 28th, 2019 • Baker Bros. Advisors Lp • Services-medical laboratories • New York
Contract Type FiledFebruary 28th, 2019 Company Industry JurisdictionWHEREAS, the Agent, in his capacity as a director of Genomic Health, Inc. (the “Company”), received non-transferable options (the “Options”) to purchase 8,250 shares of the Company common stock (the “Stock”) according to the below Schedule A;
PROCEEDS AGREEMENTProceeds Agreement • January 30th, 2017 • Baker Bros. Advisors Lp • Biological products, (no disgnostic substances) • New York
Contract Type FiledJanuary 30th, 2017 Company Industry JurisdictionAGREEMENT dated as of January 26, 2017 by and between Baker Bros. Advisors LP (the “Management Company”) and Michael Goller (the “Agent”).
PROCEEDS AGREEMENTProceeds Agreement • May 3rd, 2018 • Baker Bros. Advisors Lp • Services-commercial physical & biological research • New York
Contract Type FiledMay 3rd, 2018 Company Industry JurisdictionWHEREAS, the Agent, in his capacity as a director of Incyte Corporation (the “Company”), received non-transferable options (the “Options”) to purchase 20,000 shares of the Company common stock (the “Stock”) according to the below Schedule A;
PROCEEDS AGREEMENTProceeds Agreement • May 19th, 2016 • Baker Julian • Services-medical laboratories • New York
Contract Type FiledMay 19th, 2016 Company Industry JurisdictionWHEREAS, the Agent, in his capacity as a director of Genomic Health, Inc. (the “Company”), received non-transferable options (the “Options”) to purchase 8,250 shares of the Company common stock (the “Stock”) according to the below Schedule A;
PROCEEDS AGREEMENTProceeds Agreement • March 17th, 2016 • Baker Julian • Services-commercial physical & biological research • New York
Contract Type FiledMarch 17th, 2016 Company Industry JurisdictionWHEREAS, the Agent, in his capacity as a director of Incyte Corporation (the “Company”), received non-transferable options (the “Options”) to purchase 20,000 shares of the Company common stock (the “Stock”) according to the below Schedule A;
PROCEEDS AGREEMENTProceeds Agreement • February 16th, 2016 • Baker Bros. Advisors Lp • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 16th, 2016 Company Industry JurisdictionAGREEMENT dated as of February 11, 2016 by and between Baker Bros. Advisors LP (the “Management Company”) and Michael Goller (the “Agent”).
PROCEEDS AGREEMENTProceeds Agreement • June 1st, 2017 • Baker Bros. Advisors Lp • Services-medical laboratories • New York
Contract Type FiledJune 1st, 2017 Company Industry JurisdictionWHEREAS, the Agent, in his capacity as a director of Genomic Health, Inc. (the “Company”), received non-transferable options (the “Options”) to purchase 8,250 shares of the Company common stock (the “Stock”) according to the below Schedule A;
PROCEEDS AGREEMENTProceeds Agreement • April 28th, 2017 • Baker Bros. Advisors Lp • Services-commercial physical & biological research • New York
Contract Type FiledApril 28th, 2017 Company Industry JurisdictionWHEREAS, the Agent, in his capacity as a director of Incyte Corporation (the “Company”), received non-transferable options (the “Options”) to purchase 20,000 shares of the Company common stock (the “Stock”) according to the below Schedule A;
1 EXHIBIT 10.10 PROCEEDS AGREEMENT THIS AGREEMENT dated as of April 5, 1999 is made by and among PHILIP SERVICES CORP. ("PSC"), PHILIP SERVICES (DELAWARE), INC. ("PSI" and, together with PSC, the "Borrowers") and each of the direct and indirect...Proceeds Agreement • April 29th, 1999 • Philip Services Corp • Sanitary services • Ontario
Contract Type FiledApril 29th, 1999 Company Industry Jurisdiction
1 EXHIBIT 10.6 PROCEEDS AGREEMENT The undersigned parties to the Merger Agreement and Plan of Reorganization dated as of May 17, 2000 (the "Merger Agreement") hereby agree as follows (any capitalized terms not defined herein having the meanings given...Proceeds Agreement • May 23rd, 2000 • Professional Transportation Group LTD Inc • Arrangement of transportation of freight & cargo
Contract Type FiledMay 23rd, 2000 Company Industry
PROCEEDS AGREEMENTProceeds Agreement • April 29th, 2020 • Baker Bros. Advisors Lp • Services-commercial physical & biological research • New York
Contract Type FiledApril 29th, 2020 Company Industry JurisdictionWHEREAS, the Agent, in his capacity as a director of Incyte Corporation (the “Company”), received non-transferable options (the “Options”) to purchase 20,000 shares of the Company common stock (the “Stock”) according to the below Schedule A;
PROCEEDS AGREEMENTProceeds Agreement • June 26th, 2018 • Baker Bros. Advisors Lp • Biological products, (no disgnostic substances) • New York
Contract Type FiledJune 26th, 2018 Company Industry JurisdictionWHEREAS, the Agent, in his capacity as a director of DBV Technologies S.A. (the “Company”), received non-transferable warrants (the “Warrants”) to purchase 7,000 shares of the Company common stock (the “Stock”) according to the below Schedule A;
PROCEEDS AGREEMENTProceeds Agreement • March 12th, 2018 • Baker Bros. Advisors Lp • Services-medical laboratories • New York
Contract Type FiledMarch 12th, 2018 Company Industry JurisdictionWHEREAS, the Agent, in his capacity as a director of Genomic Health, Inc. (the “Company”), received non-transferable options (the “Options”) to purchase 8,250 shares of the Company common stock (the “Stock”) according to the below Schedule A;
EXHIBIT E PROCEEDS AGREEMENT [HSBC Bank USA Letterhead] December 14, 2005Proceeds Agreement • December 20th, 2005 • Royal Gold Inc • Mineral royalty traders
Contract Type FiledDecember 20th, 2005 Company IndustryThis is to advise you that HSBC Bank USA (“HSBC”) has continued a credit facility in favor of Royal Gold, Inc. (“Royal Gold”) pursuant to the Amended and Restated Loan Agreement dated as of December 14, 2005 between HSBC and Royal Gold (the “Loan Agreement”), which amends and restates in its entirety the Loan Agreement dated as of December 18, 2000 between HSBC and Royal Gold. The Loan Agreement is secured by various collateral security arrangements, including: (1) a lien and security interest in favor of HSBC on Royal Gold’s share of all mineral production (“Production”) from the GSR#1 Royalty, the GSR#3 Royalty and the NVR#1 Royalty, each on the Pipeline/South Pipeline Mining Complex in Lander County, Nevada (the “Project”), (2) a security interest in all proceeds of such Production (“Proceeds”), and (3) a security interest in all accounts of Royal Gold, whether metals or monetary, and credit balances therein, with Johnson Matthey Inc. (“Accounts”).